Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes

The recent series of large genome-wide association studies in European and Japanese cohorts established that Parkinsondisease(PD)hasasubstantialgeneticcomponent.TofurtherinvestigatethegeneticlandscapeofPD, weperformed agenome-widescaninthelargesttodateAshkenaziJewishcohortof1130Parkinsonpatientsand 2611 pooled controls. Motivated by the reduced disease allele heterogeneity and a high degree of identical-by-descent (IBD) haplotype sharing in this founder population, we conducted a haplotype association study based on mapping of shared IBD segments. We observed significant haplotype association signals at three previously implicated Parkinson loci: LRRK2 (OR 5 12.05, P 5 1.23 3 10 2 56 ), MAPT (OR 5 0.62, P 5 1.78 3 10 2 11 ) and GBA (multiple distinct haplotypes, OR > 8.28, P 5 1.13 3 10 2 11 and OR 5 2.50, P 5 1.22 3 10 2 9 ). In addition, we identified a novel association signal on chr2q14.3 coming from a rare haplotype (OR 5 22.58, P 5 1.21 3 10 2 10 ) and replicated it in a secondary cohort of 306 Ashkenazi PD cases and 2583 controls. Our results highlight the power of our haplotype association method, particularly useful in studies of founder populations, and reaffirm the benefits of studying complex diseases in Ashkenazi Jewish cohorts.

[1]  Mohamad Saad,et al.  Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinsons disease (vol 22, pg 1696, 2013) , 2013 .

[2]  Mohamad Saad,et al.  Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. , 2013, Human molecular genetics.

[3]  Jennifer Mulle,et al.  A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci , 2012, PLoS genetics.

[4]  Alexander Gusev,et al.  The architecture of long-range haplotypes shared within and across populations. , 2012, Molecular biology and evolution.

[5]  A. Mirelman,et al.  Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. , 2012, Archives of neurology.

[6]  Itsik Pe'er,et al.  Implications for health and disease in the genetic signature of the Ashkenazi Jewish population , 2012, Genome Biology.

[7]  Karen Marder,et al.  Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population , 2011, BMC Medical Genetics.

[8]  Alexander Gusev,et al.  DASH: a method for identical-by-descent haplotype mapping uncovers association with recent variation. , 2011, American journal of human genetics.

[9]  Nicholas Eriksson,et al.  Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.

[10]  Mohamad Saad,et al.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.

[11]  Eleazar Eskin,et al.  Increased power of mixed models facilitates association mapping of 10 loci for metabolic traits in an isolated population. , 2011, Human molecular genetics.

[12]  Matti Pirinen,et al.  Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21 , 2010, Human molecular genetics.

[13]  Nir Giladi,et al.  Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli population. , 2011, Journal of Parkinson's disease.

[14]  Jiannis Ragoussis,et al.  Characterization of a Family with Rare Deletions in CNTNAP5 and DOCK4 Suggests Novel Risk Loci for Autism and Dyslexia , 2010, Biological Psychiatry.

[15]  D. Cutler,et al.  Microdeletions of 3q29 confer high risk for schizophrenia. , 2010, American journal of human genetics.

[16]  Itsik Pe'er,et al.  Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. , 2010, American journal of human genetics.

[17]  H. Kang,et al.  Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.

[18]  Jong Jin Kim,et al.  The distribution and most recent common ancestor of the 17q21 inversion in humans. , 2010, American journal of human genetics.

[19]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[20]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[21]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[22]  Alexander Gusev,et al.  Whole population, genome-wide mapping of hidden relatedness. , 2009, Genome research.

[23]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[24]  K. Shianna,et al.  Long-range LD can confound genome scans in admixed populations. , 2008, American journal of human genetics.

[25]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[26]  Nir Giladi,et al.  The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease , 2007, Neurology.

[27]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[28]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[29]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[30]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[31]  H. Stefánsson,et al.  A common inversion under selection in Europeans , 2005, Nature Genetics.

[32]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[33]  G. Rennert,et al.  Clinical Phenotype of Families with Longevity , 2004, Journal of the American Geriatrics Society.

[34]  Karen Marder,et al.  Familial aggregation of early‐ and late‐onset Parkinson's disease , 2003, Annals of neurology.

[35]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[36]  Kei-Hoi Cheung,et al.  ALFRED: An allele frequency database for anthropology. , 2002, American journal of physical anthropology.

[37]  Nir Giladi,et al.  Cross-Sectional Study of the Prevalence of Parkinson’s Disease in the Kibbutz Movement in Israel , 2001, Neuroepidemiology.

[38]  H. Ostrer.  A genetic profile of contemporary Jewish populations , 2001, Nature Reviews Genetics.

[39]  R. Carmi,et al.  Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population , 1998, Human mutation.

[40]  Nir Giladi,et al.  Occurrence of Parkinson's syndrome in type I Gaucher disease. , 1996, QJM : monthly journal of the Association of Physicians.

[41]  A. Motulsky.  Jewish diseases and origins , 1995, Nature Genetics.

[42]  D. Benson,et al.  Alzheimer's disease and Parkinson's disease , 1988, Neurology.